Crystallization method and bioavailability
US10323052B2 · kind B2 · utility
0Cited by
44References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2017 |
| Grant date | Jun 18, 2019 |
| Priority date | — |
| Expiry date | Nov 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.